157 related articles for article (PubMed ID: 18983928)
1. Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
Kanehara M; Yokoyama A; Tomoda Y; Shiota N; Iwamoto H; Ishikawa N; Taooka Y; Haruta Y; Hattori N; Kohno N
Pulm Pharmacol Ther; 2008 Dec; 21(6):874-8. PubMed ID: 18983928
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study.
Abe T; Setoguchi Y; Kono Y; Togashi Y; Sugiyama S; Tanakadate M; Soeda S; Nakai M; Sugiyama N; Fujiwara A; Yamaguchi K; Yamaguchi A; Kurita N
Pulm Pharmacol Ther; 2011 Oct; 24(5):617-24. PubMed ID: 21689775
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
Minami S; Kawayama T; Ichiki M; Nishiyama M; Sueyasu Y; Gohara R; Kinoshita M; Koga H; Iwanaga T; Aizawa H
Intern Med; 2008; 47(6):503-9. PubMed ID: 18344636
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
Yamagata T; Hirano T; Sugiura H; Yanagisawa S; Ichikawa T; Ueshima K; Akamatsu K; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
Pulm Pharmacol Ther; 2008; 21(1):160-5. PubMed ID: 17632023
[TBL] [Abstract][Full Text] [Related]
5. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Mochizuki H; Nanjo Y; Takahashi H
Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
[TBL] [Abstract][Full Text] [Related]
6. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Fukuchi Y; Nagai A; Seyama K; Nishimura M; Hirata K; Kubo K; Ichinose M; Aizawa H;
Treat Respir Med; 2005; 4(6):447-55. PubMed ID: 16336029
[TBL] [Abstract][Full Text] [Related]
8. Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
Akamatsu K; Yamagata T; Takahashi T; Miura K; Maeda S; Yamagata Y; Ichikawa T; Yanagisawa S; Ueshima K; Hirano T; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
Pulm Pharmacol Ther; 2007; 20(6):701-7. PubMed ID: 17049894
[TBL] [Abstract][Full Text] [Related]
9. Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD.
Chen YH; Yao WZ; Ding YL; Geng B; Lu M; Tang CS
Pulm Pharmacol Ther; 2008; 21(1):40-6. PubMed ID: 17196413
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
12. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
[TBL] [Abstract][Full Text] [Related]
14. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
Hozawa S; Haruta Y; Terada M; Yamakido M
Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose theophylline on airway inflammation in COPD.
Kobayashi M; Nasuhara Y; Betsuyaku T; Shibuya E; Tanino Y; Tanino M; Takamura K; Nagai K; Hosokawa T; Nishimura M
Respirology; 2004 Jun; 9(2):249-54. PubMed ID: 15182277
[TBL] [Abstract][Full Text] [Related]
16. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
18. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function.
Kume H; Kondo M; Ito Y; Suzuki R; Yamaki K; Takagi K
Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1076-83. PubMed ID: 12390295
[TBL] [Abstract][Full Text] [Related]
19. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
[TBL] [Abstract][Full Text] [Related]
20. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
Ding YL; Yao WZ; Liu Z; Wang YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
